Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.35
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Actuate Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -24.12 | -27.29 | -24.74 | -20.16 |
| Stock-Based Compensation | 5.7 | 2 | 0.42 | 0.65 |
| Other Operating Activities | 0.02 | 2.35 | 0.12 | -0.02 |
| Change in Accounts Payable | -1 | -1.5 | 1.29 | 0.59 |
| Change in Other Net Operating Assets | -0.84 | 2.6 | 1.28 | 1.15 |
| Operating Cash Flow | -20.24 | -21.84 | -21.63 | -17.79 |
| Short-Term Debt Issued | - | 5.7 | - | - |
| Total Debt Issued | - | 5.7 | - | - |
| Short-Term Debt Repaid | - | -0.2 | - | - |
| Total Debt Repaid | - | -0.2 | - | - |
| Net Debt Issued (Repaid) | - | 5.5 | - | - |
| Issuance of Common Stock | 24.03 | 23.96 | - | - |
| Other Financing Activities | -0.38 | -1.93 | - | - |
| Financing Cash Flow | 23.64 | 27.53 | 4.13 | 19.26 |
| Net Cash Flow | 3.4 | 5.68 | -17.49 | 1.46 |
| Levered Free Cash Flow | -11.45 | -12.39 | -12.64 | - |
| Unlevered Free Cash Flow | -11.44 | -12.38 | -12.61 | - |
| Change in Working Capital | -1.84 | 1.1 | 2.57 | 1.73 |
Source: S&P Capital IQ. Standard template.
Financial Sources.